People: Alnylam Pharmaceuticals Inc (ALNY.O)
2 Oct 2015
Dr. John M. Maraganore, Ph.D., is Chief Executive Officer, Director of Alnylam Pharmaceuticals, Inc. Dr. Maraganore also served as our President from December 2002 to December 2007. From April 2000 to December 2002, Dr. Maraganore served as Senior Vice President, Strategic Product Development for Millennium Pharmaceuticals, Inc. (now a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited), a biopharmaceutical company. He also serves as a director of Agios Pharmaceuticals, Inc., bluebird bio, Inc. and the Biotechnology Industry Organization, a non-profit biotechnology trade organization, and formerly served as a director of Regulus Therapeutics Inc. from 2007 to May 2014.
|Total Annual Compensation, USD||1,133,580|
|Restricted Stock Awards, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||7,596|
|Fiscal Year Total, USD||1,141,180|